Determining ING1a induced senescence mechanisms


This study is about looking at genes related to aging. Previous work has shown that there are various ways aging impacts our bodies. Some of these impacts happen at the cellular level and some occur at deeper levels. Some recently identified genes have better correlation with known signs of aging. One such family of genes is known as the ING family, which stands for Inhibitor of Growth.

The purpose of this study is to examine blood samples from people of various age groups. By understanding how these genes work, we will gain insight into the processes of aging. This work could contribute to the eventual development of therapeutic treatments for healthy aging


Currently recruiting participants: Yes

Eligible gender: Male, Female

Eligible ages: 18 to 100

Accepts healthy participants: Yes

Inclusion criteria:

We require 40 donors in total:
- 10 female, ages 18-25
- 10 male, ages 18-25
- 10 female, older than 60 years
- 10 male, older than 60 years

Exclusion criteria:

- Individuals younger than 18 years old.
- Individuals between the ages of 26-59 years.


Fill out the following form if you want to participate in this research

Method of contact

Additional information

Contact information

You may contact Dr. Karl Riabowol at 403-220-8695 or with any questions or concerns about the research or regarding participation in this study.

Principal investigator:

Karl Riabowol

Clinical trial: